Loss of Tumorigenicity of Murine Colon Carcinoma MC38/0 Cell Line after Transduction with a Retroviral Vector Carrying Murine IL-12 Genes
Open Access
- 1 January 2004
- journal article
- Published by Charles University in Prague, Karolinum Press in Folia Biologica
- Vol. 50 (1) , 7-14
Abstract
Cells of transplantable MC38 colon carcinoma of C57BL/6 mice were adapted to growth in vitro as the MC38/0 cell line. Along the establishing process, MC38/0 cells preserved their tumorigenicity. After transduction with a retroviral vector carrying murine interleukin 12 ( mIL-12 ) genes and further selection, stable MC38/IL-12 transductant cells were obtained. These cells produced IL-12 (approx. 2500 ng/ml /5x10 5 cells /48 h) as evaluated in the optimized bioassay. After subcutaneous inoculation into syngeneic mice, the IL-12-modified cells demonstrated reduced tumorigenicity as compared to parental MC38/0 cells. Mice that rejected the MC38/IL-12 tumour became protected against subsequent challenge with MC38/0 cells. The obtained data indicate that the IL-12-transduced murine colon carcinoma cells could be used both as a model tumour for the study of mechanisms of anticancer immunity and/or as an adjuvant to cancer vaccines.Keywords
Funding Information
- Komitet Badań Naukowych (PBZ-KBN 004/PO4/98/5f)
This publication has 7 references indexed in Scilit:
- Introduction: current concepts in immunity to human cancer and therapeutic antitumor vaccinesImmunological Reviews, 2002
- IFN-γ-Inducible Protein-10 Is Essential for the Generation of a Protective Tumor-Specific CD8 T Cell Response Induced by Single-Chain IL-12 Gene TherapyThe Journal of Immunology, 2001
- The effects of peritumoral therapeutic vaccination with IL-2-secreting cells on growth of MC38 colon tumours in mice, local NO production and sentinel lymph node cells activation2001
- Synergistic antitumour effects of chemo-immunotherapy with an oxazaphosphorine drug and IL-2-secreting cells in a mouse colon cancer modelMedical Oncology, 1999
- Regulation of interferon-γ production by IL-12 and IL-18Current Opinion in Immunology, 1998
- THE INTERLEUKIN-12/INTERLEUKIN-12-RECEPTOR SYSTEM: Role in Normal and Pathologic Immune ResponsesAnnual Review of Immunology, 1998
- Gene-modified tumor cells as cellular vaccineCancer Immunology, Immunotherapy, 1996